Dr. Reddy’s is launching febuxostat tablets.
The product is the generic of Teijin Kabushiki Kaisha’s Uloric.
It is used to lower uric acid levels in people with gout.
The Uloric brand and generic had a market value of approximately $108 million for the most recent 12 months ended October 2020, according to IQVIA.
Dr. Reddy’s febuxostat tablets are available in 40 mg and 80 mg dosage strengths in bottle count sizes of 30 tablets.